Therapeutic compositions, primarily for topical application, and methods of making and using the composition. Pharmaceutical compositions formulated for specific forms of administration are also provided.

Therapeutic compositions, primarily for topical application, and methods of making and using the composition. Pharmaceutical compositions formulated for specific forms of administration are also provided.

A water absorbent agent having a high water absorption multiplying factor where stickiness after absorbing liquid can be reduced when used as a hygienic material is produce by a method for manufacturing the water absorbing agent. The method for manufacturing a water absorbent agent having a centrifuge retention capacity (CRC) of 30 g/g or greater, includes subjecting an aqueous solution of a monomer that includes an acrylic acid (salt) to a polymerization step, a drying step, and a surface cross-linking step, and a step for adding α-hydroxycarboxylic acid (salt) before the drying step. The atomic weight of the soluble portion eluted when the water absorbent agent absorbs liquid and swells can be reduced by the α-hydroxycarboxylic acid (salt) before the drying step to reduce the stickiness of the water absorbent agent after absorption of liquid, which leads to discomfort during use of disposable diapers and the like.

A water absorbent agent having a high water absorption multiplying factor where stickiness after absorbing liquid can be reduced when used as a hygienic material is produce by a method for manufacturing the water absorbing agent. The method for manufacturing a water absorbent agent having a centrifuge retention capacity (CRC) of 30 g/g or greater, includes subjecting an aqueous solution of a monomer that includes an acrylic acid (salt) to a polymerization step, a drying step, and a surface cross-linking step, and a step for adding α-hydroxycarboxylic acid (salt) before the drying step. The atomic weight of the soluble portion eluted when the water absorbent agent absorbs liquid and swells can be reduced by the α-hydroxycarboxylic acid (salt) before the drying step to reduce the stickiness of the water absorbent agent after absorption of liquid, which leads to discomfort during use of disposable diapers and the like.

The present invention relates to compositions and methods for malodor reduction. The malodor control compositions are suitable for use in a variety of applications, including use in consumer products, for example, air freshening compositions, laundry detergents, fabric enhancers, surface cleaners, beauty care products, dish care products, diapers, feminine protection articles, animal and pet litter compositions and plastic films for garbage bags. Such malodor control technologies do not unduly interfere with the scent of the perfumed or unperfumed situs that is treated with the malodor control technology.

The present invention relates to compositions and methods for malodor reduction. The malodor control compositions are suitable for use in a variety of applications, including use in consumer products, for example, air freshening compositions, laundry detergents, fabric enhancers, surface cleaners, beauty care products, dish care products, diapers, feminine protection articles, animal and pet litter compositions and plastic films for garbage bags. Such malodor control technologies do not unduly interfere with the scent of the perfumed or unperfumed situs that is treated with the malodor control technology.

This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.

This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.

A tackifier composition comprising at least one thermoplastic hydrocarbon resin and an antioxidant composition is provided; wherein a portion of the volatile organic compounds in the thermoplastic hydrocarbon resin has been removed; wherein the antioxidant composition comprises at least one primary antioxidant and at least one secondary antioxidant; and wherein the levels of individual volatile organic compound monitored in the tackifier composition are less than about 0.5 ppm as measured by GC/MS headspace analysis. Processes for producing the tackifier composition are also provided as well as adhesives comprising the tackifier compositions.

A tackifier composition comprising at least one thermoplastic hydrocarbon resin and an antioxidant composition is provided; wherein a portion of the volatile organic compounds in the thermoplastic hydrocarbon resin has been removed; wherein the antioxidant composition comprises at least one primary antioxidant and at least one secondary antioxidant; and wherein the levels of individual volatile organic compound monitored in the tackifier composition are less than about 0.5 ppm as measured by GC/MS headspace analysis. Processes for producing the tackifier composition are also provided as well as adhesives comprising the tackifier compositions.